Noveris Health Sciences is trading 7.14% up at CA$0.07, with no clear catalyst identified.
- Shares were CA$0.07 at the October 2 close.
- No October 5 company announcement was identified. The latest releases listed on the company’s news page concern its annual meeting and a proposed convertible-debenture placement; neither establishes a reason for the move.
- Available evidence does not support attributing the move to broader market sentiment.